Glycated ECM Derived Carbon Dots Inhibit Tumor Vasculogenic Mimicry by Disrupting RAGE Nuclear Translocation and Its Interaction With HMGB1
Advanced Materials · 2025
DOI: 10.1002/adma.202419540 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2025. Verfasst von Shaoting Zheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, China. Hauptthemen laut MEDLINE: HMGB1 Protein, Extracellular Matrix, Receptor for Advanced Glycation End Products, Carbon. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
This study investigates the role of advanced glycation end‐products (AGEs) in tumor vasculogenic mimicry (VM). Using high‐sugar diet animal models and glycated extracellular matrix (ECM) ex vivo models, AGEs derived is demonstrated from glycated ECM significantly enhanced tumor growth and VM formation. However, carbon dots (egCDs) derived from glycated ECM effectively inhibit tumor growth and VM formation in this glycated microenvironment. Mechanistic studies show that AGEs from glycated ECM bind to the Receptor of Advanced Glycation Endproducts (RAGE) receptors on tumor cells, promoting RAGE nuclear translocation and binding with high mobility group box 1 (HMGB1), which increases the transcription of Snail family transcriptional repressor 2 (SNAI2), thereby driving VM formation. However, egCDs competitively bind to RAGE, promoting its lysosomal degradation and blocking VM formation induced by the RAGE‐HMGB1‐SNAI2 axis. In conclusion, this study demonstrates that egCDs can target RAGE and promote its lysosomal degradation to block VM formation induced by glycated ECM. This finding not only reveals the transformation of glycated ECM from a pro‐VM factor to an anti‐VM therapeutic agent after carbonization, but also provides a theoretical basis for the innovative strategy of “reconstructing pathogenic substances into carbon dots to reverse disease‐driving factors into therapeutic targeting carriers”.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, China.
- Tianjin International Joint Academy of Biomedicine, Tianjin, China.
ORCID-Profile: Tao Sun
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Zheng, S., Zhang, X., Yang, F., Chang, Z., Han, J., Zhang, H., Liu, H., & Sun, T. (2025). Glycated ECM Derived Carbon Dots Inhibit Tumor Vasculogenic Mimicry by Disrupting RAGE Nuclear Translocation and Its Interaction With HMGB1. Advanced Materials. https://doi.org/10.1002/adma.202419540
Vancouver
Zheng S, Zhang X, Yang F, Chang Z, Han J, Zhang H, et al. Glycated ECM Derived Carbon Dots Inhibit Tumor Vasculogenic Mimicry by Disrupting RAGE Nuclear Translocation and Its Interaction With HMGB1. Advanced Materials. 2025. doi:10.1002/adma.202419540
BibTeX
@article{Zheng2025,
author = {Zheng, Shaoting and Zhang, Xiaoyan and Yang, Fan and Chang, Zhi and Han, Jingxia and Zhang, Heng and Liu, Huijuan and Sun, Tao},
title = {Glycated ECM Derived Carbon Dots Inhibit Tumor Vasculogenic Mimicry by Disrupting RAGE Nuclear Translocation and Its Interaction With HMGB1},
journal = {Advanced Materials},
year = {2025},
doi = {10.1002/adma.202419540}
}
EUVIMED